Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Daptomycin Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. The global ...

Please provide your email address to receive an email when new articles are posted on . Daptomycin costs more to acquire, but the overall treatment cost is less than with vancomycin. Daptomycin ...

July 24, 2008 — Daptomycin was effective for skin and skin structure infections (SSSI), with similar outcomes for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S ...

Following her admission to intensive care unit, the patient’s daptomycin treatment was discontinued due to concern for potential daptomycin-induced hepatotoxicity. Liver function tests (LFTs) showed ...

April 11, 2012 (London, United Kingdom) — Daptomycin (Cubicin, Novartis) achieves clinical cure rates of 72% in sepsis caused by Staphylococcus aureus and of 85% in sepsis caused by Staphylococcus ...

Concerns were raised about the efficacy of daptomycin for MRSA bloodstream infections in patients with impaired renal function (CrCl <50mL/min) after a recent FDA package insert change with additional ...

Review the side-effects of Daptomycin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Methicillin-resistant Staphylococcus Aureus (MRSA) is the most common bacteria which is difficult to treat particularly in children as it may cause complicated skin and skin structure infections. A ...

We reviewed the medical records of one neonate and one infant treated with daptomycin for MRSA infection in whom drug concentrations were obtained. Daptomycin blood monitoring is not widely available ...

Compared with standard of care, once-daily daptomycin, a parenteral lipopeptide antibiotic, demonstrated significant effectiveness and safety for the treatment of complicated skin and skin structure ...

Pharmaceutical company Accord Healthcare is recalling 350mg and 500mg vials of the nationally distributed antibiotic daptomycin due to a product mix-up, the Food and Drug Administration announced ...

On Wednesday, Civica Rx, a nonprofit drug company founded last year by a consortium of hospitals and foundations, said it had entered an agreement with a Danish drugmaker to make available injected ...